Argatroban and catheter-directed thrombolysis with alteplase for limb- and graft-threatening thromboses in a patient with a history of HIT.
Maldonado
Angela
A
Kidney Transplant Program, Providence Sacred Heart Medical Center, Spokane, WA, USA. angela.maldonado@providence.org
D000368:Aged; D017153:Antibodies, Anticardiolipin / Q000097:blood; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives; D002404:Catheterization; D000075202:Contraindications; D004359:Drug Therapy, Combination; D005268:Femoral Vein; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007084:Iliac Vein; D007262:Infusions, Intravenous; D007511:Ischemia / Q000209:etiology; D007668:Kidney / Q000098:blood supply; D016030:Kidney Transplantation; D008297:Male; D010875:Pipecolic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D011152:Popliteal Vein; D011183:Postoperative Complications / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D018455:Protein S Deficiency / Q000150:complications; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000139:chemically induced* / Q000150:complications; D012082:Renal Veins; D013449:Sulfonamides; D015912:Thrombolytic Therapy / Q000379:methods*; D019851:Thrombophilia / Q000235:genetics / Q000276:immunology; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D016306:Vena Cava Filters; D020246:Venous Thrombosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D014859:Warfarin / Q000627:therapeutic use
D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; D010875:Pipecolic Acids; D013449:Sulfonamides; D014859:Warfarin; D006493:Heparin; D001120:Arginine; D010959:Tissue Plasminogen Activator; C031942:argatroban